Medico Remedies Ltd. | Small-cap | Healthcare
₹39.80
-1.78%
| Medico Remedies Stock Comparison:
Medico Remedies vs Sun PharmaceuticalMedico Remedies vs Divi's LaboratoriesMedico Remedies vs Sun Pharma AdvancedMedico Remedies vs Aarti DrugsMedico Remedies vs Sequent ScientificMedico Remedies vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 382.5M
Gross Profit 109.1M 28.53%
Operating Income 20.6M 5.38%
Net Income 18.2M 4.75%
EPS (Diluted) ₹0.22

Balance Sheet Metrics

Total Assets 1.2B
Total Liabilities 573.3M
Shareholders Equity 624.7M
Debt to Equity 0.92

Cash Flow Metrics

Revenue & Profitability Trend

Medico Remedies Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i1.5B1.4B1.4B1.2B1.2B
Cost of Goods Sold i1.2B1.2B1.1B957.3M989.8M
Gross Profit i295.8M247.1M257.7M226.2M208.6M
Gross Margin % i19.9%17.2%18.6%19.1%17.4%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i106.8M67.7M123.2M118.6M110.6M
Other Operating Expenses i-982.0K7.3M120.0K4.6M6.4M
Total Operating Expenses i105.8M74.9M123.4M123.2M117.0M
Operating Income i119.7M100.3M69.0M53.1M55.6M
Operating Margin % i8.1%7.0%5.0%4.5%4.6%
Non-Operating Items
Interest Income i1.0M937.0K1.0M703.0K4.2M
Interest Expense i8.5M6.4M5.8M5.1M7.9M
Other Non-Operating Income-----
Pre-tax Income i135.0M113.3M101.0M64.8M37.0M
Income Tax i34.1M30.4M28.6M16.7M11.1M
Effective Tax Rate % i25.3%26.9%28.3%25.8%30.0%
Net Income i100.9M82.9M72.4M48.1M25.9M
Net Margin % i6.8%5.8%5.2%4.1%2.2%
Key Metrics
EBITDA i173.9M177.3M161.2M116.2M81.1M
EPS (Basic) i₹1.22₹1.00₹0.87₹0.58₹0.31
EPS (Diluted) i₹1.22₹1.00₹0.87₹0.58₹0.31
Basic Shares Outstanding i8298400082984000829840008298400082984000
Diluted Shares Outstanding i8298400082984000829840008298400082984000

Income Statement Trend

Medico Remedies Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i10.9M1.8M9.1M11.6M28.3M
Short-term Investments i14.5M13.6M12.7M11.8M11.7M
Accounts Receivable i571.8M496.3M360.9M303.9M265.8M
Inventory i267.3M163.4M197.0M181.1M145.5M
Other Current Assets747.0K1.1M969.0K5.5M7.4M
Total Current Assets i966.8M737.6M645.4M575.7M577.3M
Non-Current Assets
Property, Plant & Equipment i5.7M5.4M4.4M1.6M1.5M
Goodwill i662.0K1.2M700.0K00
Intangible Assets i662.0K1.2M700.0K--
Long-term Investments-----
Other Non-Current Assets1.7M1.0K2.2M-1.0K1.0K
Total Non-Current Assets i231.2M224.3M229.1M198.3M170.9M
Total Assets i1.2B962.0M874.5M774.0M748.2M
Liabilities
Current Liabilities
Accounts Payable i347.1M315.1M309.9M271.0M253.5M
Short-term Debt i143.3M71.8M84.6M100.3M101.0M
Current Portion of Long-term Debt-----
Other Current Liabilities-1.0K1.0K14.2M6.8M-1.0K
Total Current Liabilities i569.6M428.1M417.7M381.4M379.3M
Non-Current Liabilities
Long-term Debt i3.7M8.7M13.0M25.7M49.5M
Deferred Tax Liabilities i01.4M1.9M00
Other Non-Current Liabilities1.0K-1.0K1.0K-1.0K6.0K
Total Non-Current Liabilities i3.7M10.1M18.4M26.9M50.7M
Total Liabilities i573.3M438.2M436.1M408.3M430.0M
Equity
Common Stock i166.0M166.0M166.0M166.0M41.5M
Retained Earnings i423.0M322.1M239.2M166.7M118.6M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i624.7M523.7M438.4M365.7M318.2M
Key Metrics
Total Debt i147.0M80.5M97.6M126.0M150.5M
Working Capital i397.1M309.5M227.7M194.3M198.0M

Balance Sheet Composition

Medico Remedies Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i100.9M82.9M72.4M48.1M25.9M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i-104.5M-96.8M-65.8M-32.4M-419.8M
Operating Cash Flow i-3.7M-13.7M7.9M18.0M-384.7M
Investing Activities
Capital Expenditures i-31.8M-24.7M-65.9M-29.0M-169.6M
Acquisitions i-----
Investment Purchases i-875.0K-975.0K-868.0K-137.0K-3.9M
Investment Sales i26.0K--01.5M
Investing Cash Flow i-32.7M-25.7M-66.7M-29.2M-172.0M
Financing Activities
Share Repurchases i-----
Dividends Paid i-----
Debt Issuance i---049.5M
Debt Repayment i---13.0M-53.9M-
Financing Cash Flow i---26.1M66.7M171.3M
Free Cash Flow i17.0M2.0M15.7M-505.0K-282.7M
Net Change in Cash i-36.4M-39.3M-85.0M55.6M-385.4M

Cash Flow Trend

Medico Remedies Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 34.79
Price to Book 5.64
Price to Sales 2.22

Profitability Ratios

Profit Margin 6.52%
Operating Margin 5.38%
Return on Equity 16.16%
Return on Assets 8.43%

Financial Health

Current Ratio 1.70
Debt to Equity 23.53
Beta 0.02

Per Share Data

EPS (TTM) ₹1.22
Book Value per Share ₹7.53
Revenue per Share ₹19.11

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
medico3.5B34.795.6416.16%6.52%23.53
Sun Pharmaceutical 3.9T37.745.4315.08%19.29%3.26
Divi's Laboratories 1.6T70.7910.9314.64%23.89%0.03
Sun Pharma Advanced 47.8B-13.92-21.95157.88%-53.22%-1.24
Aarti Drugs 43.0B22.813.1412.28%7.80%44.92
Sequent Scientific 44.3B153.956.282.84%1.85%62.47

Financial data is updated regularly. All figures are in the company's reporting currency.